243 related articles for article (PubMed ID: 7792930)
1. 5-HT2 receptor subtypes: a family re-united?
Baxter G; Kennett G; Blaney F; Blackburn T
Trends Pharmacol Sci; 1995 Mar; 16(3):105-10. PubMed ID: 7792930
[TBL] [Abstract][Full Text] [Related]
2. Novel discriminatory ligands for 5-HT2B receptors.
Baxter GS
Behav Brain Res; 1996; 73(1-2):149-52. PubMed ID: 8788493
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological characterisation of human 5-HT2 receptor subtypes.
Jerman JC; Brough SJ; Gager T; Wood M; Coldwell MC; Smart D; Middlemiss DN
Eur J Pharmacol; 2001 Feb; 414(1):23-30. PubMed ID: 11230991
[TBL] [Abstract][Full Text] [Related]
4. Serotonin and human myoclonus. Rationale for the use of serotonin receptor agonists and antagonists.
Pranzatelli MR
Arch Neurol; 1994 Jun; 51(6):605-17. PubMed ID: 7515228
[TBL] [Abstract][Full Text] [Related]
5. Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents.
Fletcher A; Cliffe IA; Dourish CT
Trends Pharmacol Sci; 1993 Dec; 14(12):41-8. PubMed ID: 8122313
[TBL] [Abstract][Full Text] [Related]
6. The 5-HT1A receptor and its ligands: structure and function.
Olivier B; Soudijn W; van Wijngaarden I
Prog Drug Res; 1999; 52():103-65. PubMed ID: 10396127
[TBL] [Abstract][Full Text] [Related]
7. The human serotonin 5-HT2B receptor: pharmacological link between 5-HT2 and 5-HT1D receptors.
Choi DS; Birraux G; Launay JM; Maroteaux L
FEBS Lett; 1994 Oct; 352(3):393-9. PubMed ID: 7926008
[TBL] [Abstract][Full Text] [Related]
8. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
Wang CD; Gallaher TK; Shih JC
Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
[TBL] [Abstract][Full Text] [Related]
9. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore models for metabotropic 5-HT receptor ligands.
Bojarski AJ
Curr Top Med Chem; 2006; 6(18):2005-26. PubMed ID: 17017971
[TBL] [Abstract][Full Text] [Related]
11. A review of central 5-HT receptors and their function.
Barnes NM; Sharp T
Neuropharmacology; 1999 Aug; 38(8):1083-152. PubMed ID: 10462127
[TBL] [Abstract][Full Text] [Related]
12. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a novel serotonin receptor from Caenorhabditis elegans: cloning and expression of two splice variants.
Hamdan FF; Ungrin MD; Abramovitz M; Ribeiro P
J Neurochem; 1999 Apr; 72(4):1372-83. PubMed ID: 10098838
[TBL] [Abstract][Full Text] [Related]
14. Characterization of 5-hydroxytryptamine (5-HT) receptor subtypes influencing colonic motility in conscious dogs.
Nagakura Y; Kamato T; Nishida A; Ito H; Yamano M; Miyata K
Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):489-98. PubMed ID: 8740141
[TBL] [Abstract][Full Text] [Related]
15. Structural insight into the serotonin (5-HT) receptor family by molecular docking, molecular dynamics simulation and systems pharmacology analysis.
Wang YQ; Lin WW; Wu N; Wang SY; Chen MZ; Lin ZH; Xie XQ; Feng ZW
Acta Pharmacol Sin; 2019 Sep; 40(9):1138-1156. PubMed ID: 30814658
[TBL] [Abstract][Full Text] [Related]
16. Arylpiperazine derivatives acting at 5-HT(1A) receptors.
López-Rodríguez ML; Ayala D; Benhamú B; Morcillo MJ; Viso A
Curr Med Chem; 2002 Feb; 9(4):443-69. PubMed ID: 11945120
[TBL] [Abstract][Full Text] [Related]
17. Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.
Lacivita E; Patarnello D; Stroth N; Caroli A; Niso M; Contino M; De Giorgio P; Di Pilato P; Colabufo NA; Berardi F; Perrone R; Svenningsson P; Hedlund PB; Leopoldo M
J Med Chem; 2012 Jul; 55(14):6375-80. PubMed ID: 22738316
[TBL] [Abstract][Full Text] [Related]
18. 5-hydroxytryptamine (5-HT) receptor ligands.
Kitson SL
Curr Pharm Des; 2007; 13(25):2621-37. PubMed ID: 17897004
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology and Therapeutic Potential of the 5-HT
Blattner KM; Canney DJ; Pippin DA; Blass BE
ACS Chem Neurosci; 2019 Jan; 10(1):89-119. PubMed ID: 30020772
[TBL] [Abstract][Full Text] [Related]
20. Serotonin receptors: subtypes, functional responses and therapeutic relevance.
Saxena PR
Pharmacol Ther; 1995 May; 66(2):339-68. PubMed ID: 7667401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
